Status:
COMPLETED
Biodistribution of Neutrophile Proteases in the Sputum of Patients Affected by Cystic Fibrosis
Lead Sponsor:
University Hospital, Tours
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
6+ years
Brief Summary
The purpose of the proposed project is to characterize the neutrophile proteases which participate in the chronic inflammatory phenomenon associated with the cystic fibrosis and which are responsible ...
Eligibility Criteria
Inclusion
- Man /woman older than 18 years (for adult and group)
- Child aged 6 to 18 years (for child group)
- Suffering from cystic fibrosis in stable condition, ie not having presented thrust acute attack of the broncho-pulmonary or hospitalization for treatment of his illness during the previous 2 weeks
Exclusion
- colonized by Burkholderia cepacia ou Stenotrophomonas maltophilia
- non smoker (control group)
- Without history or respiratory respiratory disease known (control group)
- Antibiotic treatment and / or anti-inflammatory drug (NSAID or corticosteroids) in the 2 weeks prior to the inclusion in the study (control group)
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT00750932
Start Date
January 1 2008
End Date
January 1 2012
Last Update
February 27 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU de Tours
Tours, France, 37044